Q3 2018
Released Nov 7, 2018, before the open
10-Q filed Nov 7, 2018, 38 days after period end · 0001144204-18-057761
Q3 2018 · 10-Q
Revenue$0.00$0.00 — vs Q3 2017no prior Q2 2018 on file
Net Income-$2.46M-$2.46M N/M vs Q3 2017N/M vs Q2 2018
EPS Diluted-$0.12-$0.12 N/M vs Q3 2017N/M vs Q2 2018
Operating Income-$2,353,056N/M
Operating Cash Flowderived-$3,359,662N/M
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q3 2018 | Q3 2017 | Q3 2016 | Q3 2015 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | — | — |
| Net Income | -$2.46M | -$4.70M | -$3.24M | -$6.37M |
| EPS Diluted | -$0.12 | -$0.22 | -$0.18 | -$0.35 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Lipocine Inc. · CIK 1535955 · Engraved from SEC EDGAR